Tirzepatide combines GLP-1 and GIP receptor agonism to aid in weight loss. It enhances insulin secretion, reduces appetite, and slows gastric emptying, contributing to significant weight reduction. This medication is considered BIG guns, as it is a 2-4-1. In clinical trials patients have lost more weight in a shorter duration than with a GLP-1 alone.
.png){kind=small}
